Search results for "aortic valve replacement"

showing 3 items of 43 documents

“Unlucky punch”: unexpected annular rupture during TAVR and successful treatment

2021

Although rare, annular rupture in TAVR is a feared and often unpredictable complication with relevant impact on in-hospital prognosis. Severe annular calcification is a common risk factor for annular rupture. We report on a case of annular rupture during TAVR with a balloon-expanded prosthesis in the absence of any annular calcification in the planning CT scan and illustrate the proposed pathomechanism as well as its successful immediate surgical management.

medicine.medical_specialtymedicine.medical_treatmentComputed tomographyProsthesis DesignProsthesisTranscatheter Aortic Valve ReplacementHumansMedicineRadiology Nuclear Medicine and imagingcardiovascular diseasesRisk factorHeart Valve Prosthesis Implantationmedicine.diagnostic_testbusiness.industryCalcinosisAortic Valve Stenosisequipment and suppliesmedicine.diseaseTreatment OutcomeAortic ValveHeart Valve Prosthesiscardiovascular systemsense organsRadiologyTomography X-Ray ComputedCardiology and Cardiovascular MedicineComplicationbusinessCalcificationEchocardiography
researchProduct

RED BLOOD CELL DISTRIBUTION WIDTH PREDICTS MORBIDITY AND MORTALITY AFTER AORTIC VALVE REPLACEMENT

2014

Objective: Red blood cell distribution width (RDW), is a measurement of the size variation as well as an erythrocyte heterogeneity index (i.e., anysocytosis). used in combination with the mean corpuscular volume for anemia diagnosis. However, it is emerging as an useful predictor biomarker of mortality and morbidity of cardiovascular diseases. However, until now no literature data there are about the RDW role in predicting mortality after aortic valve replacement (AVR). Thus, in this pilot study biological significance of elevated RDW values in early outcome following AVR was evaluated Methods: We enrolled 75 patients (mean age 73.5 ±7.9 years) subjected to AVR and/ or not co temporally to …

red distribution width aortic valve replacement mortality and morbiditySettore MED/05 - Patologia ClinicaSettore MED/23 - Chirurgia Cardiaca
researchProduct

Porównanie stopnia uszkodzenia mięśnia sercowego po zastosowaniu kardioplegii krwistej i krystaloidowej u pacjentów poddanych zabiegowi izolowanej wy…

2016

Wstęp: Kardioplegina jest środkiem używanym do tymczasowego zatrzymywania czynności elektromechanicznej serca w zabiegach kardiochirurgicznych. Jest to roztwór o wysokiej zawartości jonów potasu podawany do tętnic wieńcowych w postaci zmieszanej z krwią pacjenta z oksygenatora (kardioplegina krwista) lub w postaci roztworu krystaloidowego (kardioplegina krystaloidowa). W dotychczasowych badaniach w większości wykazano wyższość kardiopleginy krwistej nad krystaliczną w operacjach pomostowania aortalno-wieńcowego (CABG). Celem niniejszego badania było sprawdzenie, czy u pacjentów poddanych izolowanemu zabiegowi wymiany zastawki aortalnej (AVR), podobnie jak w przypadku pacjentów poddanych CAB…

wymiana zastawki aortalnejkardiopleginacardioplegiaaortic valve replacementzatrzymanie krążenia indukowaneinducedheart arrestChirurgia Polska
researchProduct